Associations Between Clinical Characteristics and NT-proBNP in Heart Failure with Preserved Ejection Fraction: Data from the KaRen Study

被引：0
|
作者：
Lund, Lars H. [1 ]
Donal, Erwan [2 ]
Oger, Emmanuel [2 ]
Hage, Camilla [1 ]
Persson, Hans [1 ]
Haugen-Lofman, Ida [1 ]
Daubert, Jean-Claude [2 ]
Linde, Cecilia [1 ]
机构：
[1] Karolinska Inst, Sockholm, Sweden
[2] CHU Rennes, Sockholm, Sweden
来源：
CIRCULATION | 2012年 / 126卷 / 21期
关键词：
Heart failure; Diastolic function; Biomarkers;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18468
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic Impact of Repeated NT-proBNP Measurements in Patients With Heart Failure With Reduced Ejection Fraction
    Fuery, Michael A.
    Leifer, Eric S.
    Samsky, Marc D.
    Sen, Sounok
    O'Connor, Christopher M.
    Fiuzat, Mona
    Ezekowitz, Justin
    Pina, Ileana
    Whellan, David
    Mark, Daniel
    Felker, G. Michael
    Desai, Nihar R.
    Januzzi, James L.
    Ahmad, Tariq
    JACC-HEART FAILURE, 2024, 12 (03) : 479 - 487
  • [42] WHAT IS THE VALUE OF REPEATED NT-PROBNP MEASUREMENTS IN CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION?
    Fuery, Michael A.
    Leifer, Eric
    Samsky, Marc
    Sen, Sounok
    O'Connor, Christopher M.
    Fiuzat, Mona
    Ezekowitz, Justin A.
    Pina, Ileana L.
    Whellan, David J.
    Mark, Daniel B.
    Felker, G. Michael
    Desai, Nihar R.
    Januzzi, James L., Jr.
    Ahmad, Tariq
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 624 - 624
  • [43] Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study
    Donal, Erwan
    Lund, Lars H.
    Oger, Emmanuel
    Hage, Camilla
    Persson, Hans
    Reynaud, Amelie
    Ennezat, Pierre-Vladimir
    Bauer, Fabrice
    Sportouch-Dukhan, Catherine
    Drouet, Elodie
    Daubert, Jean-Claude
    Linde, Cecilia
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2014, 107 (02) : 112 - 121
  • [44] Clinical Characteristics of Heart Failure With Preserved Ejection Fraction in Children
    Nakagawa, Masao
    CIRCULATION JOURNAL, 2013, 77 (09) : 2249 - 2250
  • [45] NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction TRANSITION Study
    Pascual-Figal, Domingo
    Wachter, Rolf
    Senni, Michele
    Bao, Weibin
    Noe, Adele
    Schwende, Heike
    Butylin, Dmytro
    Prescott, Margaret F.
    JACC-HEART FAILURE, 2020, 8 (10) : 822 - 833
  • [46] Prognostic Value of Baseline BNP and NT-ProBNP and its Interaction With Spironolactone in Patients With Heart Failure and Preserved Ejection Fraction in the TOPCAT Trial
    Anand, Inder S.
    Solomon, Scott D.
    Claggett, Brian
    Shah, Sanjiv J.
    O'Meara, Eileen
    Boineau, Robin
    Fleg, Jerome L.
    Pfeffer, Marc A.
    Pitt, Bertram
    CIRCULATION, 2015, 132
  • [47] Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction
    Huang, Anan
    Qi, Xin
    Hou, Wenguang
    Qi, Yanfang
    Zhao, Na
    Liu, Keqaing
    ACTA CARDIOLOGICA, 2018, 73 (01) : 41 - 48
  • [48] NT-proBNP, galectin-3 and proANT levels in non-acute senile patients with heart failure with preserved ejection fraction
    Malinova, L.
    Podbolotov, R.
    Povarova, T.
    Matveev, I.
    Denisova, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 76 - 76
  • [49] CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and kidney dysfunction
    Nunez-Marin, Gonzalo
    Palau, Patricia
    Dominguez, Eloy
    de la Espriella, Rafael
    Lopez, Laura
    Flor, Cristina
    Marin, Paloma
    Lorenzo, Miguel
    Minana, Gema
    Bodi, Vicent
    Sanchis, Juan
    Nunez, Julio
    CLINICAL KIDNEY JOURNAL, 2024, 17 (08)
  • [50] The Role of NT-proBNP Levels in the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction-It Is Not Always a Hide-and-Seek Game
    Chrysohoou, Christina
    Konstantinou, Konstantinos
    Tsioufis, Kostas
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (07)
12345